Lista de obras -

1105 COMPREHENSIVE CHARACTERIZATION OF THE GENOMIC LANDSCAPE OF NON-INVASIVE GASTRIC CANCER IN THE JAPANESE POPULATION USING TWO SUSCEPTIBILITY GENES

scientific article published in 2020

<em>In vitro</em> analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism

scientific article published on 12 November 2020

A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

artículo científico publicado en 2013

Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection - Pilot study

artículo científico publicado en 2020

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

artículo científico publicado en 2021

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection

artículo científico publicado en 2016

Case of hepatocellular carcinoma with abdominis muscle metastasis

artículo científico publicado el 1 de diciembre de 2010

Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

artículo científico publicado en 2017

Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy

artículo científico publicado en 2015

Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib

artículo científico publicado en 2020

Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice

artículo científico publicado en 2019

Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability

scientific article published on 04 February 2020

Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy

scientific article published on 19 April 2020

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.

artículo científico publicado en 2015

Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones

artículo científico publicado en 2015

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.

artículo científico publicado en 2016

Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway.

artículo científico publicado en 2015

Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice

scientific article published on 14 June 2019

Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

artículo científico publicado en 2018

Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy

artículo científico publicado en 2019

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

scientific article published on 02 March 2019

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

artículo científico publicado en 2017

Impact of viral eradication by DAAs on the risk of HCC development, prognosis and portal hypertension in HCV-related compensated cirrhosis patients

artículo científico publicado en 2020

Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.

artículo científico publicado en 2015

Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab

artículo científico publicado en 2020

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

artículo científico publicado en 2014

Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

artículo científico publicado en 2017

Letter of response to the editor

artículo científico publicado en 2020

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.

artículo científico publicado en 2017

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

artículo científico publicado en 2013

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

artículo científico publicado en 2019

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

scientific article published on 17 October 2018

Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis

scientific article published on 11 September 2020

Retrospective Identification of Herpes Simplex 2 Virus-Associated Acute Liver Failure in an Immunocompetent Patient Detected Using Whole Transcriptome Shotgun Sequencing.

artículo científico publicado en 2017

Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy

scientific article published on 16 October 2019

Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases

scientific article published on 02 January 2020

Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients

artículo científico publicado en 2017

Serial profiling of circulating tumor DNA identifies biomarkers for anti-VEGF chemotherapy in mCRC patients

artículo científico publicado en 2017

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

artículo científico publicado en 2017

Signal activation of hepatitis B virus-related hepatocarcinogenesis by upregulation of SUV39h1

artículo científico publicado en 2020

Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

artículo científico publicado en 2013

Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy

scientific article published on 28 August 2019

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

artículo científico publicado en 2020

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients

artículo científico publicado en 2016

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

artículo científico publicado en 2017

Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

scientific article published on 01 May 2020

Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.

artículo científico publicado en 2014

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

artículo científico publicado en 2017

Lista de obras de

1105 COMPREHENSIVE CHARACTERIZATION OF THE GENOMIC LANDSCAPE OF NON-INVASIVE GASTRIC CANCER IN THE JAPANESE POPULATION USING TWO SUSCEPTIBILITY GENES

<em>In vitro</em> analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism

A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.

Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection - Pilot study

Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection

Case of hepatocellular carcinoma with abdominis muscle metastasis

Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.

Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy

Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib

Comparison of intracellular responses between HBV genotype A and C infection in human hepatocyte chimeric mice

Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability

Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study.

Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.

Effects of bisphosphonate zoledronic acid in hepatocellular carcinoma, depending on mevalonate pathway.

Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice

Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy

Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradiation therapy

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

Impact of viral eradication by DAAs on the risk of HCC development, prognosis and portal hypertension in HCV-related compensated cirrhosis patients

Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.

Incidence of microsatellite instability-high hepatocellular carcinoma among Japanese patients and response to pembrolizumab

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

Letter of response to the editor

Persisting risk of hepatocellular carcinoma after hepatitis C virus cure monitored by a liver transcriptome signature.

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

Real-world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus-related decompensated cirrhosis

Retrospective Identification of Herpes Simplex 2 Virus-Associated Acute Liver Failure in an Immunocompetent Patient Detected Using Whole Transcriptome Shotgun Sequencing.

Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy

Risk factors for histological progression of non-alcoholic steatohepatitis analyzed from repeated biopsy cases

Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients

Serial profiling of circulating tumor DNA identifies biomarkers for anti-VEGF chemotherapy in mCRC patients

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

Signal activation of hepatitis B virus-related hepatocarcinogenesis by upregulation of SUV39h1

Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients

The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.

Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Ultradeep sequencing study of chronic hepatitis C virus genotype 1 infection in patients treated with daclatasvir, peginterferon, and ribavirin.

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis